Top Navigation
United States
Choose your region
Don't see your region/country listed? Visit our global website
Related content
Chief Human Resources Officer Stephanie Franklin discusses our unique culture at Vertex and how we bring our culture to life.
Our CEO and President, Reshma Kewalramani shares her thoughts on how Vertex is rethinking work and education in an extremely competitive talent market
Join us as we celebrate 15 years of giving back at Vertex.
In this section
Our scientists don’t see the impossible as an obstacle; they see it as a good place to start
See where our scientific discoveries happen
Volunteers who participate in clinical trials help make new medicines a reality
Our comprehensive programs provide personalized support throughout the treatment journey with a Vertex medicine
Facts about cystic fibrosis (CF), including prevalence and the numbers of people with CF around the world estimated to be on CFTR modulators
Information about our Expanded Access program and how we evaluate requests
We work with the kidney disease community to ensure their voices are represented in all that we do
See how we're engaging with the sickle cell disease community
Read more about how we operate our business responsibly, and how in 2023 we created more ways to positively impact patients, employees, our communities and the environment
Discover how we're inspiring and equipping the next generation to love science and pursue a career in STEM
Explore our commitment to limiting our environmental impacts and operating our business in a sustainable manner
Chief Human Resources Officer Stephanie Franklin discusses Vertex’s inclusive benefits and how they are helping Vertexians.
Our commitment to inclusion, diversity and equity (ID&E) is longstanding and achieving our ambition takes collective action and shared ownership. Learn more about our approach from Vice President of Talent and ID&E Diana Cruz Solash.
Discover more about our relentless efforts to improve the lives of patients, employees and our communities.
Learn how our teams utilize real-world research to understand the lived impacts of sickle cell disease and beta thalassemia.